{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:32:21Z","timestamp":1790677941291,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.intimp.2022.108758","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T05:26:07Z","timestamp":1649395567000},"page":"108758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Association between IL-7 and primary Sj\u00f6gren's syndrome: A single-center study and a systematic scoping review"],"prefix":"10.1016","volume":"108","author":[{"given":"Yan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingwang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"jun14 1","key":"10.1016\/j.intimp.2022.108758_b0005","doi-asserted-by":"crossref","first-page":"e3821","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sjogren Syndrome","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"BMJ"},{"issue":"Suppl 126(4)","key":"10.1016\/j.intimp.2022.108758_b0010","first-page":"283","article-title":"Ten Years of the Essdai: Is It Fit for Purpose?","volume":"38","author":"De Wolff","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108758_b0015","doi-asserted-by":"crossref","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","article-title":"Eular Sj\u00f6gren's Syndrome Disease Activity Index (Essdai): A User Guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.intimp.2022.108758_b0020","first-page":"1","article-title":"Advances in Pathogenesis of Sj\u00f6gren\u2019s Syndrome","volume":"2021","author":"Tian","year":"2021","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.108758_b0025","first-page":"333","article-title":"Epithelial-Immune Cell Interplay in Primary Sj\u00f6gren Syndrome Salivary Gland","volume":"17","author":"Verstappen","year":"2021","journal-title":"Pathogenesis"},{"issue":"12","key":"10.1016\/j.intimp.2022.108758_b0030","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","article-title":"Flip the Coin: Il-7 and Il-7r in Health and Disease","volume":"20","author":"Barata","year":"2019","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108758_b0035","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s10067-013-2360-x","article-title":"Perspectives of the Relationship between Il-7 and Autoimmune Diseases","volume":"32","author":"Wang","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2022.108758_b0040","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3389\/fimmu.2020.01557","article-title":"Modulation of Signaling Mediated by Tslp and Il-7 in Inflammation, Autoimmune Diseases, and Cancer","volume":"11","author":"Markovi\u0107","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108758_b0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification Criteria for Sj\u00f6gren's Syndrome: A Revised Version of the European Criteria Proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2022.108758_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping Studies: Towards a Methodological Framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"issue":"11","key":"10.1016\/j.intimp.2022.108758_b0055","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/eji.201747140","article-title":"Il-17 Polarization of Mait Cells Is Derived from the Activation of Two Different Pathways","volume":"47","author":"Guggino","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108758_b0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/art.41558","article-title":"Interleukin-7\/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sj\u00f6gren's Syndrome","volume":"73","author":"Rivi\u00e8re","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.intimp.2022.108758_b0065","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/art.27318","article-title":"Increased Expression of Interleukin-7 in Labial Salivary Glands of Patients with Primary Sj\u00f6gren's Syndrome Correlates with Increased Inflammation","volume":"62","author":"Bikker","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2022.108758_b0070","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/rheumatology\/ker448","article-title":"Il-7 Drives Th1 and Th17 Cytokine Production in Patients with Primary Ss Despite an Increase in Cd4 T Cells Lacking the Il-7r\u03b1","volume":"51","author":"Bikker","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.intimp.2022.108758_b0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/rheumatology\/keaa105","article-title":"Lymphopenia in Primary Sj\u00f6gren's Syndrome Is Associated with Premature Aging of Na\u00efve Cd4+ T Cells","volume":"60","author":"Fessler","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.intimp.2022.108758_b0080","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/art.40182","article-title":"Increased Ccl25 and T Helper Cells Expressing Ccr9 in the Salivary Glands of Patients with Primary Sj\u00f6gren's Syndrome: Potential New Axis in Lymphoid Neogenesis","volume":"69","author":"Blokland","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.intimp.2022.108758_b0085","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/annrheumdis-2019-216588","article-title":"Salivary Gland Epithelial Cells from Patients with Sj\u00f6gren's Syndrome Induce B-Lymphocyte Survival and Activation","volume":"79","author":"Rivi\u00e8re","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2022.108758_b0090","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/annrheumdis-2011-200744","article-title":"Increased Interleukin (Il)-7r\u03b1 Expression in Salivary Glands of Patients with Primary Sjogren's Syndrome Is Restricted to T Cells and Correlates with Il-7 Expression, Lymphocyte Numbers and Activity","volume":"71","author":"Bikker","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2022.108758_b0095","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s10067-016-3406-7","article-title":"High Salivary Soluble L-Selectin and Interleukin-7 Levels in Asian Indian Patients with Primary Sj\u00f6gren's Syndrome","volume":"35","author":"Kabeerdoss","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2022.108758_b0100","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1136\/annrheumdis-2016-209236","article-title":"High Soluble Il-7 Receptor Expression in Sj\u00f6gren's Syndrome Identifies Patients with Increased Immunopathology and Dryness","volume":"75","author":"Hillen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2022.108758_b0105","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1136\/annrheumdis-2011-201026","article-title":"Clinical Efficacy of Leflunomide in Primary Sjogren's Syndrome Is Associated with Regulation of T-Cell Activity and Upregulation of Il-7 Receptor \u0391 Expression","volume":"71","author":"Bikker","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"13","key":"10.1016\/j.intimp.2022.108758_b0110","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1167\/iovs.15-17368","article-title":"Innate Immune Signaling Induces Il-7 Production, Early Inflammatory Responses, and Sj\u00f6gren's-Like Dacryoadenitis in C57bl\/6 Mice","volume":"56","author":"Zhou","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2022.108758_b0115","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.bbadis.2018.04.010","article-title":"Anti-Il-7 Receptor-\u0391 Treatment Ameliorates Newly Established Sj\u00f6gren's-Like Exocrinopathy in Non-Obese Diabetic Mice","volume":"1864","author":"Zhou","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"8","key":"10.1016\/j.intimp.2022.108758_b0120","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.38007","article-title":"Interleukin-7 Enhances the Th1 Response to Promote the Development of Sj\u00f6gren's Syndrome-Like Autoimmune Exocrinopathy in Mice","volume":"65","author":"Jin","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.intimp.2022.108758_b0125","doi-asserted-by":"crossref","first-page":"e77605","DOI":"10.1371\/journal.pone.0077605","article-title":"Innate Immune Signaling Induces Interleukin-7 Production from Salivary Gland Cells and Accelerates the Development of Primary Sj\u00f6gren's Syndrome in a Mouse Model","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.intimp.2022.108758_b0130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/ard.2006.060905","article-title":"Safety and Efficacy of Leflunomide in Primary Sj\u00f6gren's Syndrome: A Phase Ii Pilot Study","volume":"66","author":"van Woerkom","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2022.108758_b0135","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/1744666X.2019.1649596","article-title":"Predicting Lymphoma Development in Patients with Sj\u00f6gren's Syndrome","volume":"15","author":"De Vita","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.108758_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594096","article-title":"Primary Sj\u00f6gren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development","volume":"11","author":"Goules","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.108758_b0145","first-page":"2165","article-title":"Predicting Lymphoma Outcomes and Risk Factors in Patients with Primary Sj\u00f6gren's Syndrome Using Gradient Boosting Tree Ensembles","volume":"2019","author":"Pezoulas","year":"2019","journal-title":"Ann. Int. Conf. IEEE Eng. Med. Biol. Soc."},{"issue":"1","key":"10.1016\/j.intimp.2022.108758_b0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00296-014-3051-x","article-title":"Identification of Lymphoma Predictors in Patients with Primary Sj\u00f6gren's Syndrome: A Systematic Literature Review and Meta-Analysis","volume":"35","author":"Nishishinya","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.intimp.2022.108758_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02258","article-title":"Accumulation of Multipotent Hematopoietic Progenitors in Peripheral Lymphoid Organs of Mice over-Expressing Interleukin-7 and Flt3-Ligand","volume":"9","author":"Klein","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.108758_b0160","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2007.04.009","article-title":"Ectopic Lymphoid-Organ Development Occurs through Interleukin 7-Mediated Enhanced Survival of Lymphoid-Tissue-Inducer Cells","volume":"26","author":"Meier","year":"2007","journal-title":"Immunity"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922002429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922002429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:42:42Z","timestamp":1761586962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922002429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":32,"alternative-id":["S1567576922002429"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108758","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between IL-7 and primary Sj\u00f6gren's syndrome: A single-center study and a systematic scoping review","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108758"}}